Qiagen NV posts qtrly adjusted EPS $0.32
Nov 6 (Reuters) - Qiagen NV
Latest Developments forQiagen NV
- Oxford Immunotec announces update in patent infringement litigation
- Qiagen upgrades 2017 sales guidance after solid first half
- HTG Molecular Diagnostics initiates second development program under co's master agreement with unit of Qiagen N.V.
- Diasorin signs collaboration with QIAGEN to expand LIAISON test menu